Clinical and Histopathological Effects of Intracameral Ranibizumab in Experimental Trabeculectomy
Post-surgical scarring is a known cause of trabeculectomy failure. The aim of this study was to investigate the effectiveness of ranibizumab as an adjuvant anti-scarring agent in experimental trabeculectomy. Forty New Zealand white rabbits were randomised into four eye treatment groups: groups A (co...
Main Authors: | Yaakub Azhany, Wan Faiziah Wan Abdul Rahman, Hasnan Jaafar, Jen Hou Low, Wan Nazirah Wan Yusuf, Ahmad-Tajudin Liza-Sharmini, Jemaima Che Hamzah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/8/7372 |
Similar Items
-
Treatment for neovascular glaucoma with Ranibizumab and trabeculectomy
by: Jian Zhang, et al.
Published: (2019-12-01) -
Intravitreal Ranibizumab injection combined with trabeculectomy and PRP for neovascular glaucoma
by: Sheng-Fu Yang, et al.
Published: (2018-12-01) -
Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
by: Xiao-Dong Han, et al.
Published: (2021-12-01) -
Clinical observation on the treatment of neovascular glaucoma with intravitreal Ranibizumab injection combined with vitrectomy, panretinal photocoagulation and trabeculectomy
by: Rui-Feng Su, et al.
Published: (2020-08-01) -
Application of Ranibizumab at perioperative period of compound trabeculectomy in patients with neovascular glaucoma
by: Su-Ying Qin, et al.
Published: (2016-01-01)